Cancer Research Institute Defies Economic Headwinds with Record $34.4 Million Investment in Pioneering Immunotherapy Research
admin In a fiscal year characterized by widespread economic uncertainty and significant funding constraints for researchers...
biotech
FDA Panel Weighs Transformative Multi-Cancer Blood Test, Emphasizing Adherence to Existing Screenings
A pivotal discussion by an advisory panel to the U.S. Food and Drug Administration (FDA)...
Cancer Research Institute Defies Uncertainty with Record $34.4 Million Investment in Pioneering Cancer Research
There are moments when an organization’s mission is tested not by opportunity, but by uncertainty....
Merck reveals study success, and possible safety worries, for eye drug hopeful
A significant medicine acquired by Merck & Co. in a $1.3 billion buyout, Remigromig, has...
Cancer Research Institute Commits Record $34.4 Million to Advance Immunotherapy Amidst Global Funding Uncertainty
In a fiscal year characterized by widespread funding cuts and an increasingly precarious environment for...
Enveda Biosciences Secures $311 Million Series E, Accelerating AI-Driven Natural Product Pipeline into Advanced Clinical Stages
Colorado-based Enveda Biosciences, a rapidly ascending biotech firm leveraging artificial intelligence to explore the vast...
Pioneering Immunologists Converge to Honor Dr. Alexander Rudensky’s Legacy at Landmark Symposium on Immunity, Inflammation, and Tolerance
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, transcended the...
Rudensky Symposium Honors a Legacy, Illuminates Frontiers in Immunity, Inflammation, and Tolerance
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, at the...
Enveda, an AI drugmaker, banks $311M in venture funding
Colorado-based emerging biotech firm Enveda Biosciences has announced the successful closure of a Series E...
Rudensky Symposium Honors Immunological Pioneer, Illuminating Decades of Discovery in Immunity, Inflammation, and Tolerance
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, transcended the...
